Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abroad, abuse, abusive, adequacy, Adipex, advisor, alleging, Alli, aminopeptidase, amylin, antitumor, apelin, autoimmune, BayBio, belief, beloranib, benzphetamine, BIO, Biocom, biology, biotech, Bontril, breakthrough, burden, calcitonin, candidacy, cardiac, caution, cetilistat, chain, Chairman, chemotherapeutic, China, climate, collagen, committed, confidence, considerCOHBARTMto, consolidated, cytoprotection, davalintide, dedicate, desirable, deviation, Didex, diethyoproprion, disaster, disgorgement, downturn, dual, economy, Engle, epithelial, Europe, expert, extreme, facilitate, family, fibroblast, fibrotic, fluid, frontier, furnish, galectin, ghrelin, GIP, globe, Glucagon, gut, idiopathic, immune, immunologic, immunomodulatory, impossible, improper, incretin, inhibitor, injure, insider, interaction, IPF, Jolla, killing, La, latitude, leptin, lipase, lung, mandated, media, melanoma, methionine, misconduct, mitigation, monoamine, mononuclear, nanomolar, newly, Nicotrol, NK, Nontransferable, oncologic, outage, outbreak, pause, pediatric, peripheral, phendimetrazine, phentermine, potency, potent, power, presence, prophylactic, pulmonary, pursuit, quantify, reaction, recordkeeping, recovery, refined, refusal, relinquish, reparative, resource, restitution, reuptake, runway, scleroderma, seizure, shipment, Similarly, smoking, somatostatin, source, Stelic, stemming, Steven, substance, sympathomimetic, syngeneic, tab, temozolomide, Tenuate, tesofensine, therewith, timeframe, toleragen, triple, unfavorable, unmanaged, unremediated, untitled, verification, viable, viewed, warning, weak, weakened, werede, Xenical, XOMA, YY
Removed:
analyzed, antagonist, augmented, awarded, Belviq, call, caption, compensate, constant, continuation, convenient, copy, diversity, divisional, EST, estimating, forfeiture, Foundation, Inflation, inspect, installment, loan, mature, Nominating, official, optimize, optimized, OTCQX, owed, paper, placement, practice, preparer, reached, repayment, Room, superior, target, TSX, unit, unvested, Venture, Washington, yielding
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 Description of the Registrant's Securities
- 10.26 Form of Amendment to 8% Unsecured Promissory Note and Nontransferable Common Stock Purchase Warrant
- 10.27 Form of Amendment to Common Stock Purchase Warrant
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- Download Excel data file
- View Excel data file
Associated CWBR transcripts
CWBR similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(Subsection (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officers of CohBar, Inc., a Delaware corporation (the “Company”), do hereby certify that:
1. | To our knowledge, the Annual Report on Form 10-K for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Act of 1934; and |
2. | The information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company. |
March 12, 2020 | By: | /s/ Steven Engle | |
Date | Steven Engle | ||
Chief Executive Officer | |||
(Principal Executive Officer) | |||
March 12, 2020 | By: | /s/ Jeffrey F. Biunno | |
Date | Jeffrey F. Biunno | ||
Chief Financial Officer | |||
(Principal Financial and Accounting Officer) |